6月21日,生物科技公司Capricor Therapeutics Inc.(CAPR)股票恢复交易后,跌幅扩大至46%。此情况或与市场对其业务前景及财务状况的评估有关,具体原因尚待进一步披露。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.